# Liminatus Pharma, Inc.: Form 8-K, filed Aug 14, 2025

- Company: [Liminatus Pharma, Inc.](/companies/limn.md) (CIK 1971387)
- Form: 8-K
- Filed: 2025-08-14
- Accepted by EDGAR: Aug 14, 2025, 16:06 ET
- Period: 2025-08-14
- Accession: 0001104659-25-078577
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1971387/000110465925078577/tm2523534d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1971387/000110465925078577/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1971387/000110465925078577/tm2523534d1_8k.htm

Filed Aug 14, 2025.
Source: SEC EDGAR, the filing index for accession 0001104659-25-078577. Last ingested by Listed: Oct 24, 2026, 15:16 ET. No prices; not investment advice.